-
Mashup Score: 2December 2024 - Volume 9 - Issue 6 : PAIN Reports - 14 day(s) ago
The open home of global research and emerging pain science, PAIN Reports is an official publication of IASP. View free articles at and learn more today!
Source: journals.lww.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 3
rphological and functional level. Methods: Forty-two men with FMS underwent a comprehensive pain-related interview and neurological examination, a questionnaire and neurophysiological assessment, and specialized small fiber tests: skin punch biopsy, quantitative sensory testing including C-tactile afferents, and corneal confocal microscopy. Data were compared with those of healthy male controls. Results: Men with FMS reported generalized and permanent pain with additional pain attacks and a mostly pressing pain character. Intraepidermal nerve fiber density was reduced at ≥1 biopsy site in 35 of 42 (83%) men with FMS (controls: 32/65, 49%). Compared with male controls, men with FMS had elevated cold (P < 0.05) and warm detection thresholds (P < 0.001) and an increased mechanical pain threshold (P < 0.05) as well as an impairment of C-tactile afferents (P < 0.05). Corneal nerve fiber density was lower in male patients with FMS vs healthy men (P < 0.01). Male FMS patients with pathologica
Source: journals.lww.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2December 2024 - Volume 9 - Issue 6 : PAIN Reports - 16 day(s) ago
The open home of global research and emerging pain science, PAIN Reports is an official publication of IASP. View free articles at and learn more today!
Source: journals.lww.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 3
rphological and functional level. Methods: Forty-two men with FMS underwent a comprehensive pain-related interview and neurological examination, a questionnaire and neurophysiological assessment, and specialized small fiber tests: skin punch biopsy, quantitative sensory testing including C-tactile afferents, and corneal confocal microscopy. Data were compared with those of healthy male controls. Results: Men with FMS reported generalized and permanent pain with additional pain attacks and a mostly pressing pain character. Intraepidermal nerve fiber density was reduced at ≥1 biopsy site in 35 of 42 (83%) men with FMS (controls: 32/65, 49%). Compared with male controls, men with FMS had elevated cold (P < 0.05) and warm detection thresholds (P < 0.001) and an increased mechanical pain threshold (P < 0.05) as well as an impairment of C-tactile afferents (P < 0.05). Corneal nerve fiber density was lower in male patients with FMS vs healthy men (P < 0.01). Male FMS patients with pathologica
Source: journals.lww.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 3
rphological and functional level. Methods: Forty-two men with FMS underwent a comprehensive pain-related interview and neurological examination, a questionnaire and neurophysiological assessment, and specialized small fiber tests: skin punch biopsy, quantitative sensory testing including C-tactile afferents, and corneal confocal microscopy. Data were compared with those of healthy male controls. Results: Men with FMS reported generalized and permanent pain with additional pain attacks and a mostly pressing pain character. Intraepidermal nerve fiber density was reduced at ≥1 biopsy site in 35 of 42 (83%) men with FMS (controls: 32/65, 49%). Compared with male controls, men with FMS had elevated cold (P < 0.05) and warm detection thresholds (P < 0.001) and an increased mechanical pain threshold (P < 0.05) as well as an impairment of C-tactile afferents (P < 0.05). Corneal nerve fiber density was lower in male patients with FMS vs healthy men (P < 0.01). Male FMS patients with pathologica
Source: journals.lww.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0
al clinically important difference (MCID) is a composite outcome developed to provide a comprehensive assessment of chronic pain in response to intervention, across 5 outcome domains: pain intensity, health-related quality of life, sleep quality, physical, and emotional function. To focus on domains where the individual need is greatest, the holistic MCID reflects the cumulative MCID averaged over only the domains where subjects were impaired preintervention. Objectives: To assess the internal and construct validity of the Holistic MCID score to inform its future use as an evidence-based tool. Methods: This validation study was undertaken using data from the EVOKE trial with 111 patients up to 24-month follow-up. Internal consistency of the holistic MCID was assessed using Cronbach alpha statistic and dimensional exploration using principal component analysis. Results: The holistic MCID measure demonstrated strong internal consistency with Cronbach alpha >0.7 at all follow-ups. Princip
Source: journals.lww.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2December 2024 - Volume 9 - Issue 6 : PAIN Reports - 18 day(s) ago
The open home of global research and emerging pain science, PAIN Reports is an official publication of IASP. View free articles at and learn more today!
Source: journals.lww.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0
al clinically important difference (MCID) is a composite outcome developed to provide a comprehensive assessment of chronic pain in response to intervention, across 5 outcome domains: pain intensity, health-related quality of life, sleep quality, physical, and emotional function. To focus on domains where the individual need is greatest, the holistic MCID reflects the cumulative MCID averaged over only the domains where subjects were impaired preintervention. Objectives: To assess the internal and construct validity of the Holistic MCID score to inform its future use as an evidence-based tool. Methods: This validation study was undertaken using data from the EVOKE trial with 111 patients up to 24-month follow-up. Internal consistency of the holistic MCID was assessed using Cronbach alpha statistic and dimensional exploration using principal component analysis. Results: The holistic MCID measure demonstrated strong internal consistency with Cronbach alpha >0.7 at all follow-ups. Princip
Source: journals.lww.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0
al clinically important difference (MCID) is a composite outcome developed to provide a comprehensive assessment of chronic pain in response to intervention, across 5 outcome domains: pain intensity, health-related quality of life, sleep quality, physical, and emotional function. To focus on domains where the individual need is greatest, the holistic MCID reflects the cumulative MCID averaged over only the domains where subjects were impaired preintervention. Objectives: To assess the internal and construct validity of the Holistic MCID score to inform its future use as an evidence-based tool. Methods: This validation study was undertaken using data from the EVOKE trial with 111 patients up to 24-month follow-up. Internal consistency of the holistic MCID was assessed using Cronbach alpha statistic and dimensional exploration using principal component analysis. Results: The holistic MCID measure demonstrated strong internal consistency with Cronbach alpha >0.7 at all follow-ups. Princip
Source: journals.lww.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 1
e investigated the extent to which EIHypo and/or EIHyper occur among healthy participants and whether these responses are associated with individuals’ pain modulation capacity. Methods: Fifty-seven participants (mean age 29.20 ± 5.21 years) underwent testing of pressure pain threshold as an index of EIHypo/EIHyper: pain adaptation, offset analgesia (OA), and conditioned pain modulation as indices of pain modulation, prior to and immediately postsubmaximal isometric exercise (n = 40) or rest (n = 17, control group). Body awareness and exercise-evoked stress were also evaluated. Test–retest repeatability of the pain modulation indices was performed as well. Results: Twenty-four participants (60%) exhibited EIHypo, whereas 16 (40%) exhibited EIHyper. Pressure pain threshold did not change in the control group. Baseline (preexercise) OA efficacy predicted EIHypo/EIHyper. Furthermore, OA significantly decreased postexercise in the EIHyper subgroup and slightly increased in the EIHypo subgro
Source: journals.lww.comCategories: General Medicine News, RheumatologyTweet
The December issue of #PainReports is out now! Read all 24 articles for free at https://t.co/5qQFndz3VV https://t.co/WTmAhUKfgG